Working towards the next breakthrough in protein discovery

– Meet the people behind our treatment pipeline

Jesper works in diabetes research at Novo Nordisk

In the film below, Vice President of Diabetes Protein & Peptide Chemistry, Jesper Lau talks about the scientific journey that he takes every day in designing new protein peptides. Working with a team of protein chemists and engineers, Jesper is constantly trying to understand "how nature works in details", so that he can design protein peptides that meet the clinical needs of people living with diabetes.


Engineering proteins is like putting pearls on a string



Diabetes research at Novo Nordisk

Our science is driven by a determination to improve treatment options and advance the search for a cure for diabetes. 

Our comprehensive diabetes portfolio is a key differentiator because it demonstrates our commitment to deliver needs-based treatments that empower people with diabetes to live life on their own terms.


Other portraits in this series

 
diabetes
research 		Haemophilia research Inflammation research Device
innovation 

 



 

  •  

Science and innovation in diabetes at Novo Nordisk

Novo Nordisk diabetes research and development pipeline

Novo Nordisk Diabetes Research Unit

Our partnership focus in diabetes research

Diabetes Innovation Award Program 

Hagedorn Research Institute

  •  
  •  

Learn more about Novo Nordisk's commitment to people with diabetes:

DAWN2 Study (Diabetes, Attitudes, Wishes and Needs)

Changing Diabetes® 

Novo Nordisk World Diabetes Foundation

  •  
  •  

Type 1 diabetes centre opened in Seattle

The Novo Nordisk Type 1 Diabetes R&D Center opened 13 June, 2012 in Seattle, Washington. The centre, led by Matthias von Herrath, will work closely with academic and biotech partners, as well as conduct in-house research to develop potential new treamtent solutions for patients.

Learn more about the new centre 

  •